HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of a spirocyclic cyclodipeptide derivate of MIF on passive avoidance behavior and amnesia in rats.

Abstract
Cyclo (1-amino-1-cyclopentane-carbonyl-L-alanyl)-c(Acp-Ala), a derivative of MIF (prolyl-leucyl-glycinamide) affected passive avoidance behavior of rats when administered at different phases of the step-through type of experimental paradigm. c(Acp-Ala) given s.c. or orally in a 1 mg/kg dose increased avoidance latencies not only when administered before, or immediately after the shock trial but also when given before the pretraining trial, i.e. at the first exposure of animals to the experimental situation without shock treatment. The notion is discussed, that it is the influence of c(Acp-Ala) on processing of information received during the pretraining trial that manifests itself in the facilitation of avoidance response. The drug appears to have a long-term action since it was active when given 20 h before the pretraining trial or the shock trial or the test of retention. c(Acp-Ala) when administered immediately after the shock trial, attenuated amnesia in rats induced by electroconvulsive shock (ECS).
AuthorsI Krejcí, A Dlabac, J Vanzura, J Kosnar
JournalActivitas nervosa superior (Act Nerv Super (Praha)) Vol. 28 Issue 4 Pg. 241-6 (Dec 1986) ISSN: 0001-7604 [Print] Czech Republic
PMID2881422 (Publication Type: Journal Article)
Chemical References
  • Neuropeptides
  • Peptides, Cyclic
  • cyclo(alanine-(1-amino-1-cyclopentane)carbonyl)
  • MSH Release-Inhibiting Hormone
Topics
  • Animals
  • Avoidance Learning (drug effects)
  • Electroshock
  • MSH Release-Inhibiting Hormone (analogs & derivatives, pharmacology)
  • Male
  • Memory (drug effects)
  • Neuropeptides
  • Peptides, Cyclic (pharmacology)
  • Rats
  • Rats, Inbred Strains
  • Reaction Time

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: